Cerebral hemodynamics and systemic endothelial function are already impaired in well-controlled type 2 diabetic patients, with short-term disease

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Palazzo, Paola ^a,b   Maggio, Paola ^a   Altavilla, Riccardo ^a   Di Flaviani, Alessandra ^c   Giordani, Ilaria ^c   Malandrucco, Ilaria ^c   Picconi, Fabiana ^c   Passarelli, Francesco ^b   Pasqualetti, Patrizio ^d   Ercolani, Matilde ^b   Vernieri, Fabrizio ^a   Frontoni, Simona ^c  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b SAN GIOVANNI CALIBITA FATEBENEFRATELLI HOSPITAL   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; METFORMIN;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BRAIN HEMODYNAMICS; CEREBRAL VASOMOTOR REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC PATIENT; DIET THERAPY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FLOW MEDIATED DILATION; HEMODYNAMICS; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RISK FACTOR; SHEAR RATE; SYSTEMIC CIRCULATION; SYSTEMIC ENDOTHELIAL FUNCTION;

AGED; AUTONOMIC NERVOUS SYSTEM; CASE-CONTROL STUDIES; CEREBROVASCULAR CIRCULATION; DIABETES MELLITUS, TYPE 2; DIABETIC DIET; ENDOTHELIUM, VASCULAR; FEMALE; HEMODYNAMICS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; TIME FACTORS; VASODILATION; VASOMOTOR SYSTEM;

EID: 84896714796     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083287     Document Type: Article

References (35)

1. Vernieri F, Pasqualetti P, Matteis M, Passarelli F, Troisi E, et al. (2001) Effect of collateral blood flow and cerebral vasomotor reactivity on the outcome of carotid artery occlusion. Stroke 32: 1552-8. (Pubitemid 32631904)
2. Silvestrini M, Vernieri F, Pasqualetti P, Matteis M, Passarelli F, et al. (2000) Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA 283: 2122-7. (Pubitemid 30241308)
3. Palazzo P, Balucani C, Barlinn K, Tsivgoulis G, Zhang Y, et al. (2010) Association of reversed Robin Hood syndrome with risk of stroke recurrence. Neurology 75: 2003-8.
4. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, et al. (2002) International Brachial Artery Reactivity Task Force: Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. Journal of American College of Cardiology 39: 257-265. (Pubitemid 34084631)
5. Shechtera MK, Issachara A, Maraia I, Koren-Moraga N, Freinark D, et al. (2009) Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease. International Journal of Cardiology 134: 52-58.
6. Santos-García D, Blanco M, Serena J, Rodríguez- Yáñez M, Leira R, et al. (2011) Impaired brachial flow-mediated dilation is a predictor of a new-onset vascular event after stroke. Cerebrovasc Dis 32: 155-62.
7. Fülesdi B, Limburg M, Bereczki D, Káplár M, Molnár C, et al. (1999) Cerebrovascular reactivity and reserve capacity in type II diabetes mellitus. J Diabetes Complications 13: 191-9.
8. Kozera GM, Wolnik B, Kunicka KB, Szczyrba S, Wojczal J, et al. (2009) Cerebrovascular reactivity, intima-media thickness, and nephropathy presence in patients with type 1 diabetes. Diabetes Care 32: 878-82.
9. van Oers CA, Manschot SM, van Huffelen AC, Kappelle LJ, Biessels GJ, et al. (2006) Cerebrovascular reserve capacity is preserved in a population-based sample of patients with type 2 diabetes mellitus. Cerebrovasc Dis 22: 46-50. (Pubitemid 43875160)
10. Engelke KA, Williams MM, Dietz NM, Joyner MJ (1997) Does sympathetic activation blunt nitric oxide-mediated hyperemia in the human forearm? Clin Auton Res 7: 85-91. (Pubitemid 27198835)
11. Dyson KS, Shoemaker JK, Hughson RL (2006) Effect of acute sympathetic nervous system activation on flow-mediated dilation of brachial artery. Am J Physiol Heart Circ Physiol 290: 1446-53.
12. Vernieri F, Assenza G, Maggio P, Tibuzzi F, Zappasodi F, et al. (2010) Cortical neuromodulation modifies cerebral vasomotor reactivity. Stroke 41: 2087-90.
13. LeMarbre G, Stauber S, Khayat RN, Puleo DS, Skatrud JB, et al. (2003) Baroreflex-induced sympathetic activation does not alter cerebrovascular CO2 responsiveness in humans. J Physiol 551: 609-16. (Pubitemid 37121717)
14. European Carotid Surgery Trialists' Collaborative Group (1998) Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 351: 1379-87.
15. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, et al. (2007) Mannheim carotid intima-media thickness consensus (2004-2006): An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 23: 75-80. (Pubitemid 46112808)
16. Ewing DJ, Martyn CN, Young RJ, Clarke BF (1985) The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 8: 491-498. (Pubitemid 15240914)
17. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, et al. (2010) Toronto Diabetic Neuropathy Expert Group Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33: 2285-93.
18. Pyke KE, Tschakovsky ME (2005) The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function. Journal of Physiology 568: 357-369. (Pubitemid 41555444)
19. Markus H, Cullinane M (2001) Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion. Brain 124: 457-67. (Pubitemid 32221313)
20. Vuletić V, Cengić L, Basić S, Sporis D, Rahelić D, et al. (2011) Impaired cerebral vasoreactivity in type 2 diabetes mellitus. Coll Antropol 35: 27-31.
21. Verdelho A, Madureira S, Moleiro C, Ferro JM, Santos CO, et al. (2010) White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology 75: 160-7.
22. Silvestrini M, Pasqualetti P, Baruffaldi R, Bartolini M, Handouk Y, et al. (2006) Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease. Stroke 37: 1010-5.
23. Yokoyama H, Sone H, Saito K, Yamada D, Honjo J, et al. (2011) Flow-mediated dilation is associated with microalbuminuria independent of cardiovascular risk factors in type 2 diabetes - interrelations with arterial thickness and stiffness. J Atheroscler Thromb 18: 744-52.
24. Kotb NA, Gaber R, Salah W, Elhendy A (2012) Relations among Glycemic Control, Circulating Endothelial Cells, Nitric Oxide, and Flow Mediated Dilation in Patients with Type 2 Diabetes Mellitus. Exp Clin Endocrinol Diabetes 120: 460-5.
25. Moens AL, Goovaerts I, Claeys MJ, Vrints CJ (2005) Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool? Chest 127: 2254-63.
26. Cosentino F, Hishikawa K, Katusic ZS, Lüscher TF (1997) High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96: 25-8. (Pubitemid 27298398)
27. Wolff SP, Dean RT (1987) Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem J 245: 243-50. (Pubitemid 17089839)
28. Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, et al. (2008) Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 57: 1349-54.
29. Di Flaviani A, Picconi F, Di Stefano P, Giordani I, Malandrucco I, et al. (2011) Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients. Diabetes Care 34: 1605-9.
30. Agelink MW, Malessa R, Baumann B, Majewski T, Akila F, et al. (2001) Standardized tests of heart rate variability: normal ranges obtained from 309 healthy humans, and effects of age, gender, and heart rate. Clin Auton Res 11: 99-108. (Pubitemid 33027945)
31. Pretnar-Oblak J, Šabovič M, Zaletel M (2007) Associations between systemic and cerebral endothelial impairment determined by cerebrovascular reactivity to L-Arginine. Endothelium 14: 1-8.
32. Palazzo P, Maggio P, Passarelli F, Altavilla R, Altamura C, et al. (2013) Lack of correlation between cerebral vasomotor reactivity and flow-mediated dilation in subjects without vascular disease. Ultrasound in Medicine & Biology 39: 10-5.
33. Wang Q, Pelligrino DA, Baughman VL, Koenig HM, Albrecht RF (1995) The role of neuronal nitric oxide synthase in regulation of cerebral blood flow in normocapnia and hypercapnia in rats. J Cereb Blood Flow Metab 15: 774-778.
34. White RP, Deane C, Vallance P, Markus HS (1998) Nitric oxide synthase inhibition in humans reduces cerebral blood flow but not the hyperemic response to hypercapnia. Stroke 29: 467-472. (Pubitemid 28086693)
35. Iadecola C, Pelligrino DA, Moskowitz MA, Lassen NA (1994) Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab 14: 175-92. (Pubitemid 24064431)